InSightec, a Dallas TX-based developer of a non-invasive therapy platform, closed a $59M Series D financing.
The round was led by major institutional investors in the United States and Asia. The company announced the option for existing shareholders to invest additional equity of $3.5 million through January 30, 2015.
Led by Dr. Kobi Vortman, CEO, and newly appointed Executive Chairman Dr. Maurice R. Ferré, a seasoned medical device executive, InSightec is a world leader in MR-guided Focused Ultrasound (MRgFUS). The company, founded in 1999, has developed a completely non-invasive therapy platform adopted by world recognized physicians in more than 120 leading medical facilities around the world.